Who are Coya Therapeutics, Inc.'s main suppliers?

Coya Therapeutics, Inc. (COYA) key suppliers include: LEERINK-PARTNERS-LLC, ARS, DRL, THE-METHODIST-HOSPITAL. View the full supplier network at chainsifter.com/chain/COYA.

Who are Coya Therapeutics, Inc.'s major customers?

Coya Therapeutics, Inc. (COYA) key customers include: LEERINK-PARTNERS-LLC, DR-REDDY-S-LABS, GREENLIGHT-CAPITAL. View the full customer network at chainsifter.com/chain/COYA.

What sector is Coya Therapeutics, Inc. in?

Coya Therapeutics, Inc. (COYA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

COYA Supply Chain: Coya Therapeutics, Inc. Supplier List & 9 Relationships

4Suppliers

3Customers

2Debt Items

0Related Chains

Coya Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
LEERINK-PARTNERS-LLC	LEERINK-PARTNERS-LLC	92%	The Company has agreed to pay Leerink Partners a commission of 3.0% of the aggregate gross proceeds from any Placement Shares sold by Leerink Partners
ARS	ARS	90%	In consideration for the ARS Option, we paid ARS a one-time, non-refundable, non-creditable option fee of $0.1 million.
DRL	DRL	90%	In consideration for the license, we paid a non-refundable upfront fee of $0.4 million.
THE-METHODIST-HOSPITAL	THE-METHODIST-HOSPITAL	85%	As part of the Methodist License Agreement, we will pay Methodist a four-figure license maintenance fee annually until the first sale of licensed product occurs.

Coya Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
LEERINK-PARTNERS-LLC	LEERINK-PARTNERS-LLC	92%	The Company may offer and sell, from time to time through or to Leerink Partners, shares of the Company’s common stock
DR-REDDY-S-LABS	DR-REDDY-S-LABS	90%	The Purchasers in the Offering are Dr. Reddy’s Labs ($10.0 million) and Greenlight Capital ($1.1 million), an existing institutional stockholder of the Company.
GREENLIGHT-CAPITAL	GREENLIGHT-CAPITAL	90%	The Purchasers in the Offering are Dr. Reddy’s Labs ($10.0 million) and Greenlight Capital ($1.1 million), an existing institutional stockholder of the Company.

Coya Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
COYA-DEBT-8811	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2022-12-31.
COYA-DEBT-8810	Warrants outstanding: 2141128	90%	xbrl warrant detail from xbrl 2024-12-31.

Coya Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Coya Therapeutics, Inc..

Coya Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
COYA-OWNER-DME-CAPITAL-MANAGEMENT-LP	DME Capital Management, LP	90%	13F overlay lists DME Capital Management, LP as top holder; 57 tracked holders.

Coya Therapeutics, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

Coya Therapeutics, Inc. Supply Chain